Abbott | ABT - Pre Tax Profit

Stock Price
89.43
Daily Change
-1.36 -1.50%
Monthly
-13.07%
Yearly
-32.67%
Q2 Forecast
89.18

Abbott reported $2.39B in Pre-Tax Profit for its fiscal quarter ending in March of 2026.





Pre Tax Profit Change Date
Abbott USD 2.39B 27M Mar/2026
Agilent USD 442M 1000K Sep/2025
AtriCure USD 2.36M 2.45M Dec/2025
Baxter International USD -756M 877M Dec/2025
Becton, Dickinson and Co. USD 393M 117M Dec/2025
Bio-Rad Laboratories USD 929.2M 846.3M Dec/2025
Boston Scientific USD 700M 238M Dec/2025
Cooper Companies USD 116.8M 137.4M Sep/2025
Danaher USD 1.24B 138M Mar/2026
Dexcom USD 340.7M 40.7M Dec/2025
Edwards Lifesciences USD 348.4M 51.8M Sep/2025
Globus Medical USD 143.99M 44.18M Sep/2025
Insulet USD 140.2M 17.4M Dec/2025
Integra LifeSciences USD -6.82M 524.13M Sep/2025
Intuitive Surgical USD 955.6M 100.4M Dec/2025
J&J USD 7.82B 2.86B Mar/2026
Masimo USD 74.9M 19.5M Sep/2025
Medtronic USD 2.1B 224M Sep/2025
Merit Medical Systems USD 51.06M 22.12M Dec/2025
Pfizer USD 3.33B 290M Sep/2025
Smith & Nephew USD 469M 70M Dec/2025
Solventum Corp USD 511M 149M Sep/2025
Stryker USD 1.7B 676M Dec/2025
Tandem Diabetes Care USD -25.14M 32.58M Sep/2025
Teleflex USD -438.58M 573.82M Sep/2025
Terumo JPY 45.38B 578M Dec/2025
Thermo Fisher Scientific USD 2.12B 295M Dec/2025
Zimmer Biomet Holdings USD 98M 320.7M Dec/2025